145 related articles for article (PubMed ID: 6198083)
21. [Effects of granulocyte colony-stimulating factor on experimental bleomycin-induced pulmonary fibrosis].
Skurikhin EG; Andreeva TV; Khmelevskaia ES; Ermolaeva LA; Pershina OV; Ermakova NN; Stepanova IE; Reztsova AM; Krupin VA; Gol'dberg VE; Reĭkhart DV; Dygaĭ AM
Eksp Klin Farmakol; 2012; 75(1):30-3. PubMed ID: 22442961
[TBL] [Abstract][Full Text] [Related]
22. Oxymatrine attenuates bleomycin-induced pulmonary fibrosis in mice via the inhibition of inducible nitric oxide synthase expression and the TGF-β/Smad signaling pathway.
Liu L; Lu W; Ma Z; Li Z
Int J Mol Med; 2012 May; 29(5):815-22. PubMed ID: 22367596
[TBL] [Abstract][Full Text] [Related]
23. Pulmonary toxicity of Mt. St. Helens volcanic ash. A review of experimental studies.
Martin TR; Wehner AP; Butler J
Am Rev Respir Dis; 1983 Jul; 128(1):158-62. PubMed ID: 6408960
[No Abstract] [Full Text] [Related]
24. The pulmonary toxicity of antineoplastic agents.
Ginsberg SJ; Comis RL
Semin Oncol; 1982 Mar; 9(1):34-51. PubMed ID: 6176027
[No Abstract] [Full Text] [Related]
25. Pulmonary toxicity of antineoplastic drugs.
Willson JK
Cancer Treat Rep; 1978 Dec; 62(12):2003-8. PubMed ID: 87268
[TBL] [Abstract][Full Text] [Related]
26. [Pulmonary fibrogenetic activities of pepleomycin].
Kiuchi H
Nihon Kyobu Shikkan Gakkai Zasshi; 1983 Sep; 21(9):823-8. PubMed ID: 6202914
[No Abstract] [Full Text] [Related]
27. [Pulmonary damage caused by cytostatics and paraquat (author's transl)].
Fischer G; Wöltjen HH; Schauer A
Rontgenblatter; 1981 Sep; 34(9):331-7. PubMed ID: 6169136
[TBL] [Abstract][Full Text] [Related]
28. A TSP-1 synthetic peptide inhibits bleomycin-induced lung fibrosis in mice.
Chen Y; Wang X; Weng D; Tian L; Lv L; Tao S; Chen J
Exp Toxicol Pathol; 2009 Jan; 61(1):59-65. PubMed ID: 18579356
[TBL] [Abstract][Full Text] [Related]
29. Bleomycin-induced lung injury in mice investigated by MRI: model assessment for target analysis.
Babin AL; Cannet C; Gérard C; Saint-Mezard P; Page CP; Sparrer H; Matsuguchi T; Beckmann N
Magn Reson Med; 2012 Feb; 67(2):499-509. PubMed ID: 21656559
[TBL] [Abstract][Full Text] [Related]
30. Pulmonary toxicity of antineoplastic therapy.
Kreisman H; Wolkove N
Semin Oncol; 1992 Oct; 19(5):508-20. PubMed ID: 1411649
[TBL] [Abstract][Full Text] [Related]
31. [Experimentally induced bleomycin pulmonary toxicity--comparison of the systemic (intraperitoneal) and local (intratracheal) administration].
Ekimoto H; Takahashi K; Matsuda A; Umezawa H
Gan To Kagaku Ryoho; 1983 Dec; 10(12):2550-7. PubMed ID: 6197032
[TBL] [Abstract][Full Text] [Related]
32. Netrin-1 Regulates Fibrocyte Accumulation in the Decellularized Fibrotic Sclerodermatous Lung Microenvironment and in Bleomycin-Induced Pulmonary Fibrosis.
Sun H; Zhu Y; Pan H; Chen X; Balestrini JL; Lam TT; Kanyo JE; Eichmann A; Gulati M; Fares WH; Bai H; Feghali-Bostwick CA; Gan Y; Peng X; Moore MW; White ES; Sava P; Gonzalez AL; Cheng Y; Niklason LE; Herzog EL
Arthritis Rheumatol; 2016 May; 68(5):1251-61. PubMed ID: 26749424
[TBL] [Abstract][Full Text] [Related]
33. [Pulmonary toxicity caused by drugs].
Carrión Valero F; Marín Pardo J
Arch Bronconeumol; 1999 Dec; 35(11):550-9. PubMed ID: 10687040
[No Abstract] [Full Text] [Related]
34. Pulmonary toxicity induced by pepleomycin 3-[(S)-1'-phenylethylamino] propylamino-bleomycin.
Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Shibuya M; Shimabukuro Z; Koketsu H; Nakajima T; Niitani H
Jpn J Clin Oncol; 1983 Jun; 13(2):395-410. PubMed ID: 6193296
[TBL] [Abstract][Full Text] [Related]
35. Preclinical toxicologic evaluation of bleomycin (NSC 125 066), a new antitumor antibiotic.
Thompson GR; Baker JR; Fleischman RW; Rosenkrantz H; Schaeppi UH; Cooney DA; Davis RD
Toxicol Appl Pharmacol; 1972 Aug; 22(4):544-55. PubMed ID: 4114679
[No Abstract] [Full Text] [Related]
36. Deficiency of developmental endothelial locus-1 (Del-1) aggravates bleomycin-induced pulmonary fibrosis in mice.
Kang YY; Kim DY; Lee SH; Choi EY
Biochem Biophys Res Commun; 2014 Mar; 445(2):369-74. PubMed ID: 24525119
[TBL] [Abstract][Full Text] [Related]
37. T cell independence of bleomycin-induced pulmonary fibrosis.
Helene M; Lake-Bullock V; Zhu J; Hao H; Cohen DA; Kaplan AM
J Leukoc Biol; 1999 Feb; 65(2):187-95. PubMed ID: 10088601
[TBL] [Abstract][Full Text] [Related]
38. Effect of oxygen concentration on pulmonary fibrosis caused by peplomycin in mice.
Ekimoto H; Takada K; Takahashi K; Matsuda A; Takita T; Umezawa H
J Antibiot (Tokyo); 1984 Jun; 37(6):659-63. PubMed ID: 6204963
[TBL] [Abstract][Full Text] [Related]
39. Bleomycin sensitivity of mice expressing dominant-negative p53 in the lung epithelium.
Ghosh S; Mendoza T; Ortiz LA; Hoyle GW; Fermin CD; Brody AR; Friedman M; Morris GF
Am J Respir Crit Care Med; 2002 Sep; 166(6):890-7. PubMed ID: 12231503
[TBL] [Abstract][Full Text] [Related]
40. Evaluating the inhibitory potential of sulindac against the bleomycin-induced pulmonary fibrosis in wistar rats.
Verma R; Brahmankar M; Kushwah L; Suresh B
Environ Toxicol Pharmacol; 2013 Nov; 36(3):769-78. PubMed ID: 23958969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
